The content is available as a PDF (112.4 KB).
Footnotes
Received: 10 September 1997 / Accepted: 29 September 1997
. 1997 Dec;123(11-12):581–582. doi: 10.1007/s004320050109
Challenges associated with evaluating the clinical utility of non-cytotoxic pharmaceutical agents in oncology
Maurie Markman
1
Maurie Markman
1Cleveland Clinic Cancer Center, and the Department of Hematology/Medical Oncology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA Phone: +1 216-445-6888; Fax: +1 216-444-9464, , , , US
Find articles by Maurie Markman
1Cleveland Clinic Cancer Center, and the Department of Hematology/Medical Oncology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA Phone: +1 216-445-6888; Fax: +1 216-444-9464, , , , US
Keywords: Clinical Utility, Pharmaceutical Agent
© Springer-Verlag Berlin Heidelberg 1997
PMCID: PMC12200319 PMID: 9620214